Erectile dysfunction

CLS Americas and HALO Diagnostics Initiate Prostate Cancer Clinical Study using TRANBERG Focal Laser Ablation System

Retrieved on: 
Tuesday, November 7, 2023

LOS ANGELES, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, and HALO Diagnostics , a leader in precision diagnostics and image-guided therapies (HALO Dx), today announced a 25-patient clinical study using the TRANBERG™ Thermal Therapy System to perform image-guided focal laser ablation (FLA) of low-to-intermediate risk prostate cancer in patients.

Key Points: 
  • LOS ANGELES, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, and HALO Diagnostics , a leader in precision diagnostics and image-guided therapies (HALO Dx), today announced a 25-patient clinical study using the TRANBERG™ Thermal Therapy System to perform image-guided focal laser ablation (FLA) of low-to-intermediate risk prostate cancer in patients.
  • The CLS TRANBERG System provides safe and effective focal laser ablation of low-to-medium risk prostate tumors, while also preserving healthy tissue to minimize the risk of unwanted side effects such as ED and urinary incontinence.
  • “CLS is pleased to collaborate with Dr. Scionti and HALO Diagnostics for this clinically significant study regarding the efficacy of treating prostate cancer using image-guided focal laser ablation in an ASC,” stated Michael Magnani, president of CLS Americas.
  • “HALO Diagnostic is excited to begin this clinically significant study with CLS Americas and to begin offering this safe and minimally invasive procedure with the new TRANBERG laser through our network.”

Mangoceuticals, Inc. Launches Charitable Initiative in Support of Men’s Health Awareness Month

Retrieved on: 
Thursday, November 2, 2023

Throughout November, a month dedicated to raising awareness of men’s health issues, MangoRx will donate 50 percent of all branded merchandise profits to select charitable organizations that focus on supporting education and awareness around subjects such as prostate cancer, testicular cancer, and men’s suicide.

Key Points: 
  • Throughout November, a month dedicated to raising awareness of men’s health issues, MangoRx will donate 50 percent of all branded merchandise profits to select charitable organizations that focus on supporting education and awareness around subjects such as prostate cancer, testicular cancer, and men’s suicide.
  • MangoRx dedicates its business to shattering stigmas surrounding men’s health and wellness by making advanced solutions approachable, innovative, and unapologetically fun.
  • “MangoRx empowers men to take control of their health and overall well-being,” said Jacob Cohen, MangoRx Co-Founder and CEO.
  • About one in eight men will be diagnosed with prostate cancer during his lifetime, and it’s MangoRx’s mission to create awareness and facilitate action.

University of Massachusetts Lowell Supports Young Men's Wellness in Partnership with Innovative Startup MANUAL

Retrieved on: 
Friday, October 27, 2023

WASHINGTON, Oct. 27, 2023 /PRNewswire/ -- Today, the University of Massachusetts Lowell announced a new partnership with MANUAL, an innovative online men's personal development platform, to provide young men on campus with anonymous support and resources for their physical, psychological, academic, and sexual well-being.

Key Points: 
  • WASHINGTON, Oct. 27, 2023 /PRNewswire/ -- Today, the University of Massachusetts Lowell announced a new partnership with MANUAL, an innovative online men's personal development platform, to provide young men on campus with anonymous support and resources for their physical, psychological, academic, and sexual well-being.
  • "We're proud to invest in the well-being of young men at UMass Lowell," said Ruben Sança, Director of Student Life & Well-Being at the University of Massachusetts Lowell.
  • The partnership between UMass Lowell and MANUAL represents a significant step forward in addressing men's health challenges on college campuses.
  • This year MANUAL is partnering with a diverse group of academic institutions and organizations across the country, including Elmhurst University, Indiana University, the University of Mississippi, and the University of the Virgin Islands.

Mangoceuticals Launches TikTok Influencer Initiative and Becomes the Presenting Sponsor of the Only Stans Podcast with Glenny Balls

Retrieved on: 
Thursday, October 26, 2023

Dallas, Texas, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ED) drug branded “Mango,” is excited to announce the official launch of the Company’s new TikTok and Instagram Social Media Influencer Initiative, featuring top relevant influencers with vast global fan bases on the world’s leading social media platforms.

Key Points: 
  • MangoRx has been a key sponsor of Barstool Sports podcasts since June 2023.
  • Barstool Sports is one of the most widely followed influencer brands in the men’s health space, pulling in 15 million followers on Instagram and 33.3 million more on TikTok.
  • Glenny Balls, through his own brand, has cultivated an audience of over 300k on Instagram and more than 243k on TikTok.
  • In the immediate future, the Company will focus on tapping into Glenny Balls and his powerful audience reach to promote the MangoRx brand through the Old Row TikTok account ( www.tiktok.com/@oldrowofficial ).

CLS Americas Announces Kearney Urology Center will use its TRANBERG Laser to Provide Focal Laser Ablation Treatments to Prostate Cancer Patients

Retrieved on: 
Tuesday, October 24, 2023

In the US, over one million prostate biopsies are performed every year leading to a diagnosis of prostate cancer for almost 250,000 men.

Key Points: 
  • In the US, over one million prostate biopsies are performed every year leading to a diagnosis of prostate cancer for almost 250,000 men.
  • “We are excited to begin offering this new minimally invasive focal laser ablation treatment to our patients with low-to-intermediate risk prostate cancer.
  • The CLS Laser is very precise, easy to operate, and the treatment workflow is similar to prostate cryotherapy procedures,” stated Garrett D. Pohlman, M.D., Kearney Urology Center.
  • “CLS Americas is pleased to provide the Kearney Urology Center, PC with the training, use, and clinical support of our TRANBERG focal laser ablation system,” stated Michael Magnani, president of CLS Americas.

Mangoceuticals, Inc. Provides Update to Shareholders on Q3 Achievements and Guidance on Year End and Near-Term Initiatives

Retrieved on: 
Thursday, October 19, 2023

Customer Acquisition: To date, we have successfully onboarded a rapidly growing customer base with an Average Order Value (AOV) of $105.

Key Points: 
  • Customer Acquisition: To date, we have successfully onboarded a rapidly growing customer base with an Average Order Value (AOV) of $105.
  • We have also launched an aggressive email marketing campaign to reach out to customer leads that have expressed interest in our products.
  • To date, we have received positive results and plan to continue these efforts on an ongoing basis.
  • Subscription sales increased 65% from Q1 to Q3, with Q2 to Q3 sequential growth of 47%, demonstrating an accelerating growth curve.

Sexual Wellness Centers of America Awarded the First and Only Global Erectile Dysfunction Trademark Patent for its REGENmax Protocol that Reverses ED in 97% of men

Retrieved on: 
Tuesday, October 24, 2023

COLLEYVILLE, Texas, Oct. 24, 2023 /PRNewswire/ -- Sexual Wellness Centers of America (SWC) proudly announces its issuance and assignment of US patent number 11,806,301 for the world's first Erectile Dysfunction (ED) global trademark patent of its REGENmax protocol.

Key Points: 
  • COLLEYVILLE, Texas, Oct. 24, 2023 /PRNewswire/ -- Sexual Wellness Centers of America (SWC) proudly announces its issuance and assignment of US patent number 11,806,301 for the world's first Erectile Dysfunction (ED) global trademark patent of its REGENmax protocol.
  • Erectile dysfunction affects tens of millions of men worldwide, significantly impacting their quality of life and self-esteem.
  • The REGENmax protocol has solved the root causes of ED through a multi-faceted approach, with no need for pills or surgical intervention.
  • Sexual Wellness Centers of America now intends to extend the reach of its REGENmax protocol to the over 56 MM and growing men suffering from ED.

Mangoceuticals Announces TV Air Dates for Interview Featuring CEO Jacob Cohen on Bloomberg TV and Fox Business

Retrieved on: 
Friday, October 13, 2023

In the interview, Mr. Cohen begins by laying out the Company’s potent strategy for differentiating itself as a new breed of men’s health product provider.

Key Points: 
  • In the interview, Mr. Cohen begins by laying out the Company’s potent strategy for differentiating itself as a new breed of men’s health product provider.
  • According to Cohen, it starts with the idea of an “Erectile Function” pill instead of an “Erectile Dysfunction” pill.
  • Through that idea, Cohen believes the Company is positioning itself to tap into the relatively untapped younger demographic, which is mirrored by MangoRx’s dynamic marketing strategy.
  • Through its network of syndication, FMW programming reaches an estimated 540 million homes across US and international markets.

Mangoceuticals Announces the Official Launch of MangoRx Affiliate Marketing Program to Enhance and Accelerate Topline Growth

Retrieved on: 
Thursday, October 12, 2023

We believe that a well-executed and marketed affiliate marketing program can lead to driving more than roughly 20% of the Company’s overall gross revenue.”

Key Points: 
  • We believe that a well-executed and marketed affiliate marketing program can lead to driving more than roughly 20% of the Company’s overall gross revenue.”
    According to a recent affiliate marketing survey , the global affiliate marketing industry is worth over $17 billion and is expected to grow to a market size of $27.78 billion by 2027.
  • Additionally, 81% of brands use affiliate programs to boost brand awareness and drive sales with these affiliate marketing programs accounting for 16% of all internet orders in the U.S. Major brands get 5% to 25% of their overall online sales from affiliate marketing with 20% of brand marketers claiming affiliate marketing is their most successful revenue driving channel.
  • The Company has partnered with one of the top marketing agencies and software providers in the affiliate marketing industry to ensure all the building blocks are in place to supercharge its topline future growth.
  • We look forward to providing additional updates on this program soon.”
    To learn more about the perks and benefits of the MangoRx affiliate marketing program, visit us at www.MangoRevenue.com for more information.

CLS Americas Debuts Mobile Service Program for Office-Based Focal Laser Ablation at Western Section AUA Meeting

Retrieved on: 
Tuesday, October 3, 2023

The TRANBERG system is designed to work with multiple MR/US fusion image guidance systems for precise and accurate tumor ablation in a minimally invasive, outpatient setting in a urology office or clinic.

Key Points: 
  • The TRANBERG system is designed to work with multiple MR/US fusion image guidance systems for precise and accurate tumor ablation in a minimally invasive, outpatient setting in a urology office or clinic.
  • The system is FDA 510(k) cleared for soft tissue ablation in a urology setting.
  • Focal laser ablation of prostate tumors has demonstrated high levels of precision and accuracy with low risk of side effects, such as erectile dysfunction and urinary incontinence.
  • “We’re excited to provide our TRANBERG system to innovative urologists looking to add focal laser ablation to their practice without adding capital expense,” said Michael Magnani, president of CLS Americas.